• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受噻替派治疗的人膀胱癌细胞中,甲基黄嘌呤增强致死性。

Enhanced lethality by methylxanthines in human bladder cancer cells treated with thiotepa.

作者信息

Fingert H J, Kindy R L, Pardee A B

出版信息

J Urol. 1984 Sep;132(3):609-13. doi: 10.1016/s0022-5347(17)49759-x.

DOI:10.1016/s0022-5347(17)49759-x
PMID:6433047
Abstract

Cytotoxicity of thiotepa or doxorubicin hydrochloride in human bladder cancer cells was investigated alone and in combination with methylxanthines. Methylxanthines can potentiate cytotoxicity of some DNA-damaging agents used in cancer therapy by preventing DNA repair. However, the potential clinical utility of these drug combinations has not been defined. Nontoxic concentrations of two methylxanthines, theobromine and caffeine, markedly enhanced lethality in T-24 human bladder cancer cells treated with thiotepa. Thiotepa cytotoxicity was increased over 10-fold by continuous treatment with nontoxic concentrations of methylxanthines (0.5 mM), but the major enhancing effect was observed in the 1st 24 hours after thiotepa exposure. By contrast, no such enhanced lethality was observed using higher methylxanthine concentrations and equal or greater cytotoxic treatments with doxorubicin hydrochloride. The amount of enhanced lethality by methylxanthines correlated directly with growth rate of the cells in culture, suggesting that differential enhanced therapeutic effects could be achieved in the treatment of superficial bladder tumors based on the increased proliferative rate of neoplastic bladder cells compared to normal bladder urothelium.

摘要

研究了噻替派或盐酸多柔比星对人膀胱癌细胞的细胞毒性,以及它们与甲基黄嘌呤联合使用时的细胞毒性。甲基黄嘌呤可通过阻止DNA修复来增强癌症治疗中使用的一些DNA损伤剂的细胞毒性。然而,这些药物组合的潜在临床效用尚未明确。两种甲基黄嘌呤(可可碱和咖啡因)的无毒浓度显著增强了噻替派处理的T-24人膀胱癌细胞的杀伤力。用无毒浓度的甲基黄嘌呤(0.5 mM)持续处理可使噻替派的细胞毒性增加10倍以上,但主要增强作用在噻替派暴露后的头24小时内观察到。相比之下,使用更高浓度的甲基黄嘌呤以及与盐酸多柔比星同等或更大细胞毒性的处理方法,未观察到这种增强的杀伤力。甲基黄嘌呤增强的杀伤力与培养细胞的生长速率直接相关,这表明与正常膀胱尿路上皮相比,基于肿瘤性膀胱细胞增殖速率的增加,在浅表膀胱肿瘤的治疗中可以实现不同的增强治疗效果。

相似文献

1
Enhanced lethality by methylxanthines in human bladder cancer cells treated with thiotepa.在接受噻替派治疗的人膀胱癌细胞中,甲基黄嘌呤增强致死性。
J Urol. 1984 Sep;132(3):609-13. doi: 10.1016/s0022-5347(17)49759-x.
2
In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa.
Cancer Res. 1988 Aug 1;48(15):4375-81.
3
Verapamil enhancement of chemotherapeutic efficacy in human bladder cancer cells.维拉帕米增强人膀胱癌细胞化疗疗效
J Urol. 1984 Sep;132(3):574-6. doi: 10.1016/s0022-5347(17)49749-7.
4
Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.甲基黄嘌呤对经烷化剂处理的人类肿瘤细胞的细胞毒性、细胞周期及染色体效应。
Cancer Res. 1986 May;46(5):2463-7.
5
In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
J Urol. 1991 Mar;145(3):613-7. doi: 10.1016/s0022-5347(17)38406-9.
6
Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.卡介苗与多柔比星与噻替派:202例浅表性膀胱癌患者的随机前瞻性研究
J Urol. 1990 Mar;143(3):502-6. doi: 10.1016/s0022-5347(17)40002-4.
7
[Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
Actas Urol Esp. 1985 Mar-Apr;9(2):135-46.
8
Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
Urol Res. 1987;15(1):17-20. doi: 10.1007/BF00256329.
9
In vitro chemosensitivity of human bladder cancer.
Cancer. 1983 Apr 15;51(8):1490-6. doi: 10.1002/1097-0142(19830415)51:8<1490::aid-cncr2820510823>3.0.co;2-o.
10
Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
J Urol. 1981 May;125(5):652-4. doi: 10.1016/s0022-5347(17)55151-4.

引用本文的文献

1
Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas.用于恶性胶质瘤的颅脑放疗及顺铂、丝裂霉素-C 联合耐药调节剂治疗
J Neurooncol. 1997 Apr;32(2):161-8. doi: 10.1023/a:1005788121043.